CAS 2049872-86-6

GSK962

CAS : 2049872-86-6

GSK962

Degré de pureté : ≥98%

Masse moléculaire : 230.31g/mol

Ref: 54-BUP08716

GSK'962

CAS : 2049872-86-6

GSK'962 is a small molecule phosphodiesterase inhibitor, specifically designed to modulate intracellular signaling pathways by targeting phosphodiesterase enzymes. This compound is synthesized through complex organic chemistry techniques conducted under controlled laboratory conditions. Its primary mode of action involves the inhibition of specific phosphodiesterase enzymes, leading to an increase in intracellular levels of cyclic adenosine monophosphate (cAMP) or cyclic guanosine monophosphate (cGMP). These changes in intracellular signaling cascades have been shown to affect various physiological processes, particularly within neural and cardiovascular systems.

Formule : C₁₄H₁₈N₂O

Degré de pureté : Min. 95%

Masse moléculaire : 230.31 g/mol

Ref: 3D-ZGD87286

GSK962

CAS : 2049872-86-6

GSK962 is a GSK963 inactive enantiomer. It can be used to confirm the on-target effects.

Formule : C₁₄H₁₈N₂O

Degré de pureté : 99.75%

Couleur et forme : Solid

Masse moléculaire : 230.31

Ref: TM-T15444